Celcuity Inc. (SAVE) Leerink World Healthcare Convention 2026 March 10, 2026 2:20 PM EDT
Firm Members
Brian Sullivan – Co-Founder, Chairman & CEO
Convention Name Members
Andrew Berens – Leerink Companions LLC, Analysis Division
Presentation
Andrew Berens
Leerink Companions LLC, Analysis Division
All proper. Good afternoon, everybody. I am Andy Berens, senior biotech analyst at Leerink Companions. Thanks for becoming a member of us on day 2 of our Annual Miami Healthcare Convention. We’re very excited to have with us Brian Sullivan, CEO of Celcuity. Thanks for becoming a member of us.
Brian Sullivan
Co-Founder, Chairman & CEO
Your welcome, Pleasure.
Andrew Berens
Leerink Companions LLC, Analysis Division
You’ve got received quite a bit happening, Brian. Thanks for making time for us.
Brian Sullivan
Co-Founder, Chairman & CEO
We do, no, that is what I must do.
Query-and-Reply Session
Andrew Berens
Leerink Companions LLC, Analysis Division
For people who do not know Celcuity, are you able to give an summary of the corporate?
Brian Sullivan
Co-Founder, Chairman & CEO
Certain. Properly, I began the corporate some time in the past now to initially develop a platform with our Chief Science Officer, to isolate the exercise and quantify the exercise of stay affected person tumor cells in order that we can assist determine sufferers who is perhaps conscious of explicit focused therapies.
We started working the PI3K house and recognized what we felt was a implausible drug, gedatolisib, pan-PI3K/mTOR inhibitor and started creating that drug in ’21. Now we now have primarily accomplished 1 Part III examine. We’ve one other 1 we’ll report out quickly within the second-line setting in breast most cancers. We even have a first-line examine in course of. I am positive we’ll speak about that as effectively in breast most cancers. After which we now have an early part examine in course of in prostate most cancers.
Andrew Berens
Leerink Companions LLC, Analysis Division
Okay. Nice. Properly, you guys entered